Harel Insurance Investments & Financial Services’s AstraZeneca AZN Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-105	Closed	-$21K	–	533
2026 Q1	$21K	Sell	105 -478	-82%	-$92.2K	﹤0.01%	470
2025 Q4	$107K	Sell	583 -65	-10%	-$11.4K	﹤0.01%	311
2025 Q3	$99K	Sell	648 -72	-10%	-$10.9K	﹤0.01%	341
2025 Q2	$101K	Sell	720 -2,455	-77%	-$344K	﹤0.01%	315
2025 Q1	$467K	Buy	3,175 +411	+15%	+$59.5K	0.01%	206
2024 Q4	$362K	Buy	+2,764	New	+$387K	0.01%	173
2024 Q2	–	Sell	-377	Closed	-$51K	–	546
2024 Q1	$51K	Buy	377 +11	+3%	+$1.46K	﹤0.01%	367
2023 Q4	$49K	Sell	366 -1,144	-76%	-$149K	﹤0.01%	421
2023 Q3	$204K	Sell	1,510 -566	-27%	-$77.3K	﹤0.01%	305
2023 Q2	$294K	Buy	+2,076	New	+$305K	0.01%	265
2022 Q4	–	Sell	-503	Closed	-$55K	–	685
2022 Q3	$55K	Buy	503 +60	+14%	+$7.61K	﹤0.01%	491
2022 Q2	$58K	Buy	+443	New	+$58.1K	﹤0.01%	485
2022 Q1	–	Sell	-29	Closed	-$3K	–	710
2021 Q4	$3K	Buy	+29	New	+$3.41K	﹤0.01%	716

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Aviva London, United Kingdom $67.9B AUM 39.2% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Harel Insurance Investments & Financial Services's AZN Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 105 shares — an estimated $21K sold.

Harel Insurance Investments & Financial Services first reported a position in AZN in Q4 2021 and held it in 13 quarters. The position peaked at $467K in Q1 2025. 1,153 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Harel Insurance Investments & Financial Services reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 105 AstraZeneca shares in Q2 2026, an estimated $21K.
Harel Insurance Investments & Financial Services first reported a position in AstraZeneca in Q4 2021 and held it in 13 quarters.
Harel Insurance Investments & Financial Services's AstraZeneca position peaked at $467K in Q1 2025.
1,153 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.